Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine effects on DNIC and offset analgesia in chronic pain and healthy volunteers
2009-012586-55Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in Complex Regional Pain Syndrome Type 1 (CRPS-1), fibromyalgia (FM), Neuralgia and 2 more (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Pain relief in response to ketamine treatment as measured by OA and DNIC. Started May 2009; status: active.
02
Drugs
esketamine
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)fibromyalgia (FM)Neuralgiasmall fiber neuropathy (SFN)chronic pain
Beyond the preview
Go deeper on 2009-012586-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012586-55.